Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
As of January 02, 2026, SAB Biotherapeutics, Inc. had a $179.5 million market capitalization, putting it in the 28th percentile of companies in the Biotechnology industry. SAB Biotherapeutics, Inc.
Rhode Island firefighters rescue a yellow Lab from an icy pond on New Year's Day Skygazers advised to ‘wrap up warm’ to see Wolf supermoon Trump’s aspirin dosing ‘makes no sense’ says Dick Cheney’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback